Health Minister Harsh Vardhan says only limited quantity of Covid vaccines are expected to be available initially, and India must keep its options open.
Moderna decided to make the declaration because investors had started noticing that the company has patents that might apply to other Covid vaccines, says its president.
Dr Reddy’s had proposed to test Sputnik V in a Phase III clinical trial that generally needs to enroll over 1,000 participants. Govt panel has recommended a smaller trial instead.
At ThePrint's OTC, Dr Faheem Younus, Chief of Infectious Diseases at University of Maryland UCH, reflected on Covid vaccine race, development of treatments & South Asia's unique situation.
India’s brush with vaccine development goes back to the 19th century, when a Ukrainian bacteriologist arrived in the country to test his vaccine for cholera.
We are entering a new era of crises — in politics & biomedicine, with climate and energy, and about how we spend our time. But the truth is that progress is never going to be easy.
While vaccinating the most vulnerable makes sense, lots of good could also come from focusing resources on who is most likely to be spreading the virus.
The IndiGo crisis is nothing short of a threat to India’s stability. Could it be an experiment? Can this happen in any other crucial sector like power or railways?
RBI Handbook of Statistics shows state’s GSDP has more than doubled in past decade, finishing second behind Maharashtra. It has performed well across health & education parameters as well.
It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS